MHRA Confirms Meeting With CBD Industry Representatives.
Today, the Medicines and Healthcare products Regulatory Agency (MHRA), has arranged a meeting with representatives from the UK Cannabis Trade Association (UKCTA) to discuss its designation of cannabidiol (CBD) as a medicine.
A request for a meeting was was first made in writing on 20th September 2016, when the possibility of the MHRA’s action was still little more than a rumour. Nearly six weeks later, after repeated requests, complaints and lobbying from many companies, individuals and MPs, the meeting has been fixed for 3rd November 2016.
The main aim of the meeting will be to discuss interim arrangements for people currently using CBD as a food supplement. Clearly, we will also address concerns over the impact of this decision on many small businesses and the people they employ.